InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by Flynn Daniel Lee, Directeur Scientifique. Officer active across 1 company, notably Deciphera Pharmaceuticals, Inc.. Aggregated, 7 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €40k. Activity tracked since 15 December 2021. The latest transaction was filed on 16 June 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations7 total
1,768 shares@ US$10.7545.3% of flowCommon StockSEC:0001209191-22-038425:0
1,366 shares@ US$9.0527.4% of flowCommon StockSEC:0001209191-22-011360:0
1,366 shares@ US$9.05100.0% of flowCommon StockSEC:0001209191-22-011360
20,500 shares0Common StockSEC:0001209191-22-004074
20,500 shares0Common StockSEC:0001209191-22-004074:0
11,100 shares0Common StockSEC:0001209191-21-070227
11,100 shares0Common StockSEC:0001209191-21-070227:0
7 of 7 declarations
About Flynn Daniel Lee
Daniel Lee Flynn is Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. He is responsible for leading the company's research and development efforts. His scientific expertise is essential for the development of new treatments and for innovation within Deciphera Pharmaceuticals.
